Photo of Daniella Kadian-Dodov

Daniella Kadian-Dodov

  • ASSISTANT PROFESSOR Medicine, Cardiology
Print ProfilePrint Profile



  • American Board of Vascular Medicine

  • American Board of Internal Medicine

Clinical Focus


  • MD, Oregon Health Sciences University

  • Residency, Internal Medicine
    Mount Sinai Hospital

  • Fellowship, Vascular
    Mount Sinai Hospital


    Daniella Kadian-Dodov, MD is an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai, in the sections of  Vascular Medicine, and the Vascular Diagnostic Laboratory in the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health of The Mount Sinai Medical Center. 

    A graduate of New York University and the Oregon Health & Science University in Portland, Oregon, Dr. Kadian-Dodov completed Internal Medicine residency at the Icahn School of Medicine at Mount Sinai.  She conducted clinical research during her residency, and received accolades as both a young-investigator and educator, including the Department of Medicine Silver Apple Teaching Award.

    She has publications in basic science research regarding the behavior of vascular endothelial cells, and clinical research investigating the diagnostic role of vascular ultrasound and the clinical experience for patients with fibromuscular dysplasia.  She completed vascular medicine fellowship under the tutelage of Dr. Jeffrey Olin at the Icahn School of Medicine at Mount Sinai, and is well-versed in the management and care of patients with non-coronary vascular diseases including fibromuscular dysplasia (FMD), peripheral artery disease, renal artery disease, venous thromboembolic disease, aneurysms, spontaneous arterial dissections and other less common vascular diseases. She has a dedicated vein practice for patients with post-thrombotic syndrome, varicose veins and venous insufficiency.   She is currently involved in several research trials focused on improving knowledge in the pathophysiology, genetics, and management of FMD; as well as clinical investigator for large-scale trials in peripheral artery disease through the Icahn School of Medicine at Mount Sinai.  She is an active educator for the internal medicine housestaff and cardiology fellows, and sits on the Internal Medicine Clinical Competency Committee.


Peripheral Artery Disease

Participates in clinical trials at the Icahn School of Medicine at Mount Sinai including EUCLID and the role of ticagrelor in patients with PAD and diabetes.

Fibromuscular Dysplasia

Engaged in several studies to better understand the underlying cause of FMD, as well as the patient experience including potential underlying genetics (Define-FMD Trial), Anxiety and Depression in Patients with FMD, and the Natural History and Neurovascular Events in Patients with FMD.


Kadian-Dodov D, Papolos A, Olin JW. Diagnostic utility of carotid artery duplex ultrasonography in the evaluation of syncope: a good test ordered for the wrong reason. European heart journal cardiovascular Imaging 2015 Jun; 16(6).

Michelis KC, Olin JW, Kadian-Dodov D, d'Escamard V, Kovacic JC. Coronary artery manifestations of fibromuscular dysplasia. Journal of the American College of Cardiology 2014 Sep; 64(10).

Olin JW, Kadian-Dodov D. Exercise-induced leg pain and high blood pressure. JAMA : the journal of the American Medical Association; 311(4).

Kadian-Dodov DL, van der Zee SA, Scott SA, Peter I, Martis S, Doheny DO, Rothlauf EB, Lubitz SA, Desnick RJ, Halperin JL. Warfarin pharmacogenetics: a controlled dose-response study in healthy subjects. Vascular medicine (London, England) 2013 Oct; 18(5).

Pintucci G, Saunders PC, Gulkarov I, Sharony R, Kadian-Dodov DL, Bohmann K, Baumann FG, Galloway AC, Mignatti P. Anti-proliferative and anti-inflammatory effects of topical MAPK inhibition in arterialized vein grafts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006 Feb; 20(2).

Pintucci G, Yu PJ, Saponara F, Kadian-Dodov DL, Galloway AC, Mignatti P. PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus. Journal of cellular biochemistry 2005 Aug; 95(6).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Kadian-Dodov did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


5 East 98th Street
3rd Floor
New York, NY 10029

Tel: 212-427-1540


Guggenheim Pavilion Floor 1st Floor Room (GP) 1 Center
1190 Fifth Avenue
New York, NY 10029

The Lauder Family Cardiovascular Ambulatory Center

1190 Fifth Avenue
1st Floor
New York, NY 10029

Tel: 212-241-5627
Fax: 212-410-7196
Get Directions

Office Hours:
  • Monday 8:00am - 5:30pm
  • Thursday 1:00am - 5:30pm
Insurance Plans
  • 1199 Member Choice
  • Access Medicare
  • Aetna
  • BCBS Child Health Plus
  • BCBS Direct HMO
  • BCBS Direct POS
  • BCBS Direct Pay HMO
  • BCBS Direct Pay HMO/POS
  • BCBS DirectShare POS
  • BCBS Empire Prism EPO
  • BCBS Empire Prism PPO
  • BCBS Health New York
  • BCBS Indemnity
  • BCBS MediBlue HMO
  • BCBS MediBlue PPO
  • Cigna - HMO
  • GHI
  • HIP Commercial
  • HIP Medicaid
  • HIP Medicare
  • Medicaid of New York
  • Medicare of NY
  • MultiPlan, Inc.
  • Multiplan/PHCS
  • Oxford (Medicare)
  • Oxford Freedom
  • Oxford Liberty
  • Private Healthcare Systems (PHCS)
  • Senior Plan
  • United Healthcare
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Discover
  • Personal Check
  • Cash
  • Other
  • Credit Card (Other)